|
Issues Surrounding Prenatal Genetic Testing for Achondroplasia Clinical Trials Data presented on Clinical Trials Search isn't meant to be a substitute for qualified health advice, calls or treatment using a genuine doctor. We are not docs. Always consult your dr. on Issues Surrounding Prenatal Genetic Testing for Achondroplasia conditions. Clinical Trials Search.org is a site dedicated to listing clinical research studies in human subjects. Issues Surrounding Prenatal Genetic Testing for Achondroplasia Clinical research trials and Issues Surrounding Prenatal Genetic Testing for Achondroplasia healthcare trials occur in a lot of of places throughout the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the potency of new drugs. The intent of the studies / undertakings is to figure out certain human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector corporations to locate remedies for all kinds of circumstances, including Issues Surrounding Prenatal Genetic Testing for Achondroplasia. Issues Surrounding Prenatal Genetic Testing for Achondroplasia Clinical Trials and other clinical trials allow volunteers to obtain health treatment alternatives before they are available to the masses. Many times the participants undergo treatment for free, and sometimes they are paid for their time. Occasionally there is a cost for a Issues Surrounding Prenatal Genetic Testing for Achondroplasia clinical trial. Participants typically obtain the most effective healthcare available for their Issues Surrounding Prenatal Genetic Testing for Achondroplasia condition. Dangers are a reality, nonetheless, and can include extra or frequent mD trips, medical hazards (potentially life-endangering), and/or the treatment being uneffective. Trials are federally regulated with rigid guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Issues Surrounding Prenatal Genetic Testing for Achondroplasia  Issues Surrounding Prenatal Genetic Testing for Achondroplasia
Issues Surrounding Prenatal Genetic Testing for Achondroplasia
For Condition: Achondroplasia,Dwarfism
Status: Completed
Sponsor(s): National Human Genome Research Institute (NHGRI) ,
Synopsis: Since the gene responsible for achondroplasia was identified in 1994, it has become possible to test for achondroplasia prenatally. Moreover, prenatal genetic testing for achondroplasia is relatively simple and is highly likely to be informative for any couple seeking testing. Four diagnostic laboratories in the U.S. are currently performing prenatal genetic testing for achondroplasia. Before prenatal genetic testing for achondroplasia becomes more widely available, however, it is essential that we learn more about the lives of affected individuals and their families, the implications of offering testing for achondroplasia, and the education and the counseling needs of this community. Personal interviews and stories have been published and discussed at national meetings (Ablon 1984). We conducted a pilot telephone interview survey of 15 individuals with achondroplasia. What is needed now is a large scale quantitative study of the community of little people and their families. To meet this need, we have developed a survey tool to analyze family relationships, quality of life, tendencies toward optimism or pessimism, information-avoiding or information-seeking behaviors, social support, involvement in Little People of America Inc. (LPA), self-esteem, sociodemographics and views on achondroplasia, religiousness, reproductive and family plans, genetic testing, and abortion. The self-administered survey will be completed nationally by a sample of persons with achondroplasia and their family members.
Details: Since the gene responsible for achondroplasia was identified in 1994, it has become possible to test for achondroplasia prenatally. Moreover, prenatal genetic testing for achondroplasia is relatively simple and is highly likely to be informative for any couple seeking testing. Four diagnostic laboratories in the U.S. are currently performing prenatal genetic testing for achondroplasia. Before prenatal genetic testing for achondroplasia becomes more widely available, however, it is essential that we learn more about the lives of affected individuals and their families, the implications of offering testing for achondroplasia, and the education and the counseling needs of this community. Personal interviews and stories have been published and discussed at national meetings (Ablon 1984). We conducted a pilot telephone interview survey of 15 individuals with achondroplasia. What is needed now is a large scale quantitative study of the community of little people and their families. To meet this need, we have developed a survey tool to analyze family relationships, quality of life, tendencies toward optimism or pessimism, information-avoiding or information-seeking behaviors, social support, involvement in Little People of America Inc. (LPA), self-esteem, sociodemographics and views on achondroplasia, religiousness, reproductive and family plans, genetic testing, and abortion. The self-administered survey will be completed nationally by a sample of persons with achondroplasia and their family members.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: /
Genders: Both
Protocol Entry Criteria: Adult individuals of either gender with achondroplasia and their first degree relatives (both short and average statured) of all ethnic and cultural backgrounds. No short-statured persons with conditions other than achondroplasia. No average-statured family members of short statured persons with conditions other than achondroplasia. No minors less than 18 years of age.
Total Enrollment: 2000
Location and Contact Information:
National Human Genome Research Institute (NHGRI)
Bethesda, Maryland, 20892
United States
Additional Information:
Study ID Numbers: 960123; 96-HG-0123
Study Start Date: August 9, 1996
Record last reviewed: August 31, 1999
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00001536
Other Achondroplasia Studies:
1. Growth Hormone Therapy in Osteogenesis Imperfecta
2. Study of Skeletal Disorders and Short Stature
3. Issues Surrounding Prenatal Genetic Testing for Achondroplasia
4. Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
5. Study of Luteinizing Hormone-Releasing Hormone Analog (LHRHa) in Pubertal Patients with Extreme Short Stature
Related Studies:
Other Achondroplasia Clinical Trials
Other Maryland Clinical Trials
Other Bethesda Clinical Trials
Issues Surrounding Prenatal Genetic Testing for Achondroplasia
|
|
|
|
|
|
|
|
